Latest 8-K filings

Vitaspring Biomedical Co., Ltd. announced significant leadership changes, including the resignation of its CEO, Chairperson, CFO, and Secretary, and the appointment of new officers and a director.

Central Plains Bancshares, Inc. announced its Board of Directors has approved a new stock repurchase program, allowing for the buyback of up to 10% of outstanding shares.

DarkPulse, Inc. has entered into an exclusive patent license agreement with the U.S. Department of the Air Force for technologies related to satellite power sharing, communications, and laser generation.

NeOnc Technologies Holdings, Inc. announced the pricing of a registered direct offering of common stock and warrants, raising approximately $15 million.

MercadoLibre, Inc. announced the successful pricing of $1,000 million aggregate principal amount of 5.850% Notes due 2036.

T3 Defense Inc. announced its subsidiary Rimon Agencies Ltd. has received a $1.3 million order for power-generation systems supporting a European air-defense production line.

Tevogen Inc. has received notification from Nasdaq that it has regained compliance with the minimum market value of publicly held shares requirement.

Evolution Metals & Technologies Corp. announced initial revenue guidance for fiscal years 2026 and 2027, projecting significant growth in 2027 driven by its Pohang expansion and regulatory changes.

Theravance Biopharma has filed supplemental disclosures to its proxy statement in response to shareholder litigation concerning its proposed merger with Zymeworks, aiming to avoid delays.

Wynn Resorts Finance, an indirect subsidiary of Wynn Resorts, announced plans to offer $900 million in Senior Notes due 2035 to redeem existing 2027 Senior Notes and cover associated fees.

Tetra Tech announced a significant $500 million increase to its share repurchase program, underscoring confidence in its long-term growth and commitment to returning capital to shareholders.

TAP Real Estate Technologies, Inc. has entered into a Technology Services Agreement with Alpenhaus Resort, LLC, the new owner of Zermatt Resort, to provide digital infrastructure and strategic technology services, including tokenization exclusivity.

FDCTech, Inc. has relocated its principal executive offices from Irvine, California to Limassol, Cyprus, effective September 9, 2026, to enhance operational oversight.

The Williams Companies, Inc. has priced a public offering of $2.75 billion in senior notes across four tranches with varying maturity dates and interest rates.

Disc Medicine announced positive initial results from its RESTORE-PV Phase 2 trial of DISC-3405, demonstrating significant reductions in phlebotomy events and controlled hematocrit in polycythemia vera patients.

Arrow Financial Corporation announced its subsidiary, Upstate Agency, LLC, has agreed to acquire Skene Valley Agency, Inc., expanding its insurance operations in Washington County, New York.

Acorn Energy's OmniMetrix subsidiary has acquired the Gen-Tracker standby generator monitoring business from Generator Solutions, Inc. for $3.5 million.

BKV Corporation announced the pricing of an upsized $500 million offering of 1.625% convertible senior notes due 2031, with an option for initial purchasers to buy an additional $75 million.

Equity Lifestyle Properties presents an investor day update showcasing robust financial health, strategic growth initiatives, and favorable market positioning in manufactured housing, RV resorts, and marinas.

SKYX Platforms Corp. has signed an agreement to merge with Deako Inc., an AI smart home and lighting systems company, to expand its reach in the builder and hotel markets.

SS Innovations International, Inc. announced significant progress in global expansion, pediatric robotic surgery, and telesurgery, alongside growing installations and utilization of its SSi Mantra system.

Former U.S. Senator Joe Manchin III has resigned from the Ramaco Resources, Inc. Board of Directors to focus on his independent leadership council movement.

BioCardia announced its CEO will present regulatory and corporate progress, including updates on its CardiAMP therapy and delivery platforms, at the H.C. Wainwright conference.

Versus Systems Inc. announced the appointment of Brian Goldenberg as Chief Financial Officer, with CEO Luis Goldner no longer serving as Principal Financial Officer.

Oncolytics Biotech announced positive preclinical results for its investigational immunotherapy, pelareorep, when combined with a pan-RAS inhibitor in a colorectal cancer model.

Candel Therapeutics announced the appointment of Martine Zimmermann, Pharm.D., to its Board of Directors, effective September 8, 2026, to bolster regulatory and quality expertise.

Turn Therapeutics announced its CEO and Executive Clinical Lead will present at the Stifel 2026 Virtual Immunology and Inflammation Forum on September 23, 2026.

Commerce.com, Inc. announced a strategic operating plan to enhance profitability and free cash flow, targeting significant cost savings and authorizing a $50 million share repurchase program.

SCYNEXIS, Inc. announced the appointment of Sanjay Subramanian as Chief Financial Officer, succeeding Ivor Macleod who is retiring.

Cerenome, Inc. announced a senior secured convertible note financing of up to $20 million with 3i, LP, aimed at supporting CNSide commercial scale-up and extending cash runway into 2028.